Abstract 4916: Development of a NGS-based method for EGFRvIII detection: sequence analysis of the junction
Jianhua Zhao(Southwest Petroleum University), Jennifer J.D. Morrissette(University of Pennsylvania), Robert Daber(University of Pennsylvania), Maria Martinez-Large(Hospital of the University of Pennsylvania), Marcela V. Maus(Center for Cancer Research), Matthew Hiemenz(Foundation Medicine (United States)), Barnett Li(University of Pennsylvania), Donald M. O’Rourke(University of Pennsylvania), Shrey Sukhadia(Dartmouth–Hitchcock Medical Center), Alan Fox(Hospital of the University of Pennsylvania), David B. Roth(University of Miami), David Lieberman(University of Pennsylvania), Arati Desai(University of Pennsylvania)
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing
|Nature Biotechnology|2019|724
A genome-wide association meta-analysis identifies new childhood obesity loci
|Nature Genetics|2012|440